Loading...
Chemical structure of Lazertinib

GC19218

Lazertinib

Also known as N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenylpyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholin-4-ylphenyl]prop-2-enamide

Lazertinib is a potent, highly mutant-selective, blood-brain barrier permeable, orally available and irreversible third-generation EGFR tyrosine kinase inhibitor, and can be used in the research of non-small cell lung cancer

ChemicalCAS1903008-80-9MW554.64FormulaC30H34N8O3
CAS number
1903008-80-9
Molecular weight
554.64
Formula
C30H34N8O3
Solubility
DMSO ： 9 mg/mL (16·23 mM)
InChIKey
RRMJMHOQSALEJJ-UHFFFAOYSA-N
Catalogue number
GC19218
Brand
GLPBIO
Computed properties PubChem CID 121269225 · XLogP 3.4 · TPSA 110 Ų · H-bond donors 2
XLogP
3.4
TPSA
110 Ų
H-bond donors
2
H-bond acceptors
9
Rotatable bonds
10
Heavy atoms
41

SMILES CN(C)CC1=CN(N=C1C2=CC=CC=C2)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N5CCOCC5)OC

Computed descriptors from PubChem (CID 121269225), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.